FDA
- Status: approved
🇺🇸 non-nucleoside reverse transcriptase inhibitors in United States
non-nucleoside reverse transcriptase inhibitors (non-nucleoside reverse transcriptase inhibitors) regulatory status in United States.
Marketing authorisation
non-nucleoside reverse transcriptase inhibitors in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is non-nucleoside reverse transcriptase inhibitors approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for non-nucleoside reverse transcriptase inhibitors in United States?
French National Agency for Research on AIDS and Viral Hepatitis is the originator. The local marketing authorisation holder may differ — check the official source linked above.